APO Research
Talk to an analyst

APO RESEARCH · REPORT

HPV Testing

The human papillomavirus (HPV) test detects the presence of human papillomavirus, a virus that can lead to the development of genital warts, abnormal cervical cells or cervical cancer. The HPV testing is further classified into three sub-segments, namely, follow-up testing, co-testing, HPV primary testing.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

The human papillomavirus (HPV) test detects the presence of human papillomavirus, a virus that can lead to the development of genital warts, abnormal cervical cells or cervical cancer. The HPV testing is further classified into three sub-segments, namely, follow-up testing, co-testing, HPV primary testing.

Selected research

Market Analysis & Forecast

Global HPV Testing Market Analysis and Forecast 2026-2032

21 December 2025199 pages

Choose your research edition.

Industry ResearchHPV Testing Industry Research Report 2026110 pages · $2,950 USDIndustry Growth & TrendsGlobal HPV Testing Industry Growth and Trends Forecast to 203289 pages · $3,450 USDMarket StructureGlobal HPV Testing Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032184 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal HPV Testing Market Outlook and Growth Opportunities 2026193 pages · $4,250 USDMarket Analysis & ForecastGlobal HPV Testing Market Analysis and Forecast 2026-2032199 pages · $4,950 USD

Market perspective

The human papillomavirus (HPV) test detects the presence of human papillomavirus, a virus that can lead to the development of genital warts, abnormal cervical cells or cervical cancer. The HPV testing is further classified into three sub-segments, namely, follow-up testing, co-testing, HPV primary testing.

Global HPV Testing key players include Qiagen, Roche Diagnostics, Hologic, Abbott Laboratories, BD, etc. Global top five players hold a share about 80%.

North America is the largest market, with a share about 50%, followed by Europe and Asia-Pacific, having a total share about 45 percent.

Read the full market overview

In terms of product, Co-testing is the largest segment, with a share about 55%. And in terms of application, the largest application is Cervical Cancer Screening, followed by Vaginal Cancer Screening, etc.

Report Includes

This report presents an overview of global market for HPV Testing, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of HPV Testing, also provides the revenue of main regions and countries. Of the upcoming market potential for HPV Testing, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the HPV Testing revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global HPV Testing market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for HPV Testing revenue, projected growth trends, production technology, application and end-user industry.

HPV Testing Segment by Company

Qiagen

Roche Diagnostics

Hologic

Abbott Laboratories

BD

Seegene, Inc.

HPV Testing Segment by Type

HPV Testing

Follow-up HPV Testing

Co-testing

HPV Testing Segment by Application

Cervical Cancer Screening

Vaginal Cancer Screening

Other

HPV Testing Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global HPV Testing market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of HPV Testing and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of HPV Testing.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of HPV Testing in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of HPV Testing company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, HPV Testing revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global HPV Testing Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. HPV Testing Major Player Table 3. Follow-up HPV Testing Major Player Table 4. Co-testing Major Player Table 5. Global HPV Testing Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 6. Cervical Cancer Screening Major Player Table 7. Vaginal Cancer Screening Major Player Table 8. Other Major Player Table 9. HPV Testing Industry Trends Table 10. HPV Testing Industry Drivers Table 11. HPV Testing Industry Opportunities and Challenges Table 12. HPV Testing Industry Restraints Table 13. Global HPV Testing Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 14. Global HPV Testing Market Size by Region (2021-2026) & (US$ Million) Table 15. Global HPV Testing Market Share by Region (2021-2026) Table 16. Global HPV Testing Market Size by Region (2027-2032) & (US$ Million) Table 17. Global HPV Testing Market Share by Region (2027-2032) Table 18. Global HPV Testing Revenue by Players (US$ Million) & (2021-2026) Table 19. Global HPV Testing Revenue Market Share by Players (2021-2026) Table 20. Global HPV Testing Key Players Ranking, 2024 VS 2025 VS 2026 Table 21. Global HPV Testing Key Players Headquarters & Area Served Table 22. Global HPV Testing Players, Product Type & Application Table 23. Global HPV Testing Players Establishment Date Table 24. Global Players Market Concentration Ratio (CR5 and HHI) Table 25. Global HPV Testing by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 26. Global HPV Testing Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global HPV Testing Revenue by Type (2021-2026) & (US$ Million) Table 28. Global HPV Testing Revenue by Type (2027-2032) & (US$ Million) Table 29. Global HPV Testing Revenue Market Share by Type (2021-2026) Table 30. Global HPV Testing Revenue Market Share by Type (2027-2032) Table 31. Global HPV Testing Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 32. Global HPV Testing Revenue by Application (2021-2026) & (US$ Million) Table 33. Global HPV Testing Revenue by Application (2027-2032) & (US$ Million) Table 34. Global HPV Testing Revenue Market Share by Application (2021-2026) Table 35. Global HPV Testing Revenue Market Share by Application (2027-2032) Table 36. Qiagen Company Information Table 37. Qiagen Business Overview Table 38. Qiagen HPV Testing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 39. Qiagen HPV Testing Product Portfolio Table 40. Qiagen Recent Development Table 41. Roche Diagnostics Company Information Table 42. Roche Diagnostics Business Overview Table 43. Roche Diagnostics HPV Testing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 44. Roche Diagnostics HPV Testing Product Portfolio Table 45. Roche Diagnostics Recent Development Table 46. Hologic Company Information Table 47. Hologic Business Overview Table 48. Hologic HPV Testing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 49. Hologic HPV Testing Product Portfolio Table 50. Hologic Recent Development Table 51. Abbott Laboratories Company Information Table 52. Abbott Laboratories Business Overview Table 53. Abbott Laboratories HPV Testing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 54. Abbott Laboratories HPV Testing Product Portfolio Table 55. Abbott Laboratories Recent Development Table 56. BD Company Information Table 57. BD Business Overview Table 58. BD HPV Testing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 59. BD HPV Testing Product Portfolio Table 60. BD Recent Development Table 61. Seegene, Inc. Company Information Table 62. Seegene, Inc. Business Overview Table 63. Seegene, Inc. HPV Testing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 64. Seegene, Inc. HPV Testing Product Portfolio Table 65. Seegene, Inc. Recent Development Table 66. North America HPV Testing Revenue by Type (2021-2026) & (US$ Million) Table 67. North America HPV Testing Revenue by Type (2027-2032) & (US$ Million) Table 68. North America HPV Testing Revenue by Application (2021-2026) & (US$ Million) Table 69. North America HPV Testing Revenue by Application (2027-2032) & (US$ Million) Table 70. North America HPV Testing Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 71. North America HPV Testing Revenue by Country (2021-2026) & (US$ Million) Table 72. North America HPV Testing Revenue by Country (US$ Million) & (2027-2032) Table 73. Europe HPV Testing Revenue by Type (2021-2026) & (US$ Million) Table 74. Europe HPV Testing Revenue by Type (2027-2032) & (US$ Million) Table 75. Europe HPV Testing Revenue by Application (2021-2026) & (US$ Million) Table 76. Europe HPV Testing Revenue by Application (2027-2032) & (US$ Million) Table 77. Europe HPV Testing Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 78. Europe HPV Testing Revenue by Country (2021-2026) & (US$ Million) Table 79. Europe HPV Testing Revenue by Country (US$ Million) & (2027-2032) Table 80. China HPV Testing Revenue by Type (2021-2026) & (US$ Million) Table 81. China HPV Testing Revenue by Type (2027-2032) & (US$ Million) Table 82. China HPV Testing Revenue by Application (2021-2026) & (US$ Million) Table 83. China HPV Testing Revenue by Application (2027-2032) & (US$ Million) Table 84. Asia HPV Testing Revenue by Type (2021-2026) & (US$ Million) Table 85. Asia HPV Testing Revenue by Type (2027-2032) & (US$ Million) Table 86. Asia HPV Testing Revenue by Application (2021-2026) & (US$ Million) Table 87. Asia HPV Testing Revenue by Application (2027-2032) & (US$ Million) Table 88. Asia HPV Testing Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 89. Asia HPV Testing Revenue by Region (US$ Million) & (2021-2026) Table 90. Asia HPV Testing Revenue by Region (US$ Million) & (2027-2032) Table 91. SAMEA HPV Testing Revenue by Type (2021-2026) & (US$ Million) Table 92. SAMEA HPV Testing Revenue by Type (2027-2032) & (US$ Million) Table 93. SAMEA HPV Testing Revenue by Application (2021-2026) & (US$ Million) Table 94. SAMEA HPV Testing Revenue by Application (2027-2032) & (US$ Million) Table 95. SAMEA HPV Testing Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 96. SAMEA HPV Testing Revenue by Country (2021-2026) & (US$ Million) Table 97. SAMEA HPV Testing Revenue by Country (US$ Million) & (2027-2032) Table 98. Research Programs/Design for This Report Table 99. Authors List of This Report Table 100. Secondary Sources Table 101. Primary Sources List of Figures Figure 1. HPV Testing Image Figure 2. Global HPV Testing Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global HPV Testing Market Size Share 2021 VS 2025 VS 2032 Figure 4. HPV Testing Image Figure 5. Follow-up HPV Testing Image Figure 6. Co-testing Image Figure 7. Global HPV Testing Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 8. Global HPV Testing Market Size Share 2021 VS 2025 VS 2032 Figure 9. Cervical Cancer Screening Image Figure 10. Vaginal Cancer Screening Image Figure 11. Other Image Figure 12. Global HPV Testing Market Size (US$ Million) & (2021-2032) Figure 13. Global HPV Testing Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 14. Global HPV Testing Market Share by Region: 2021 VS 2025 VS 2032 Figure 15. Global HPV Testing Players Revenue Share Top 10 and Top 5 in 2025 Figure 16. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 17. Global HPV Testing Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 18. Global HPV Testing Revenue Market Share 2021 VS 2025 VS 2032 Figure 19. Global HPV Testing Revenue Market Share by Type (2021-2032) Figure 20. Global HPV Testing Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 21. Global HPV Testing Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 22. Global HPV Testing Revenue Market Share by Application (2021-2032) Figure 23. North America HPV Testing Revenue YoY Growth (2021-2032) & (US$ Million) Figure 24. North America HPV Testing Revenue Share by Type (2021-2032) Figure 25. North America HPV Testing Revenue Share by Application (2021-2032) Figure 26. North America HPV Testing Revenue Share by Country (2021-2032) Figure 27. United States HPV Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 28. Canada HPV Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 29. Mexico HPV Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 30. Europe HPV Testing Revenue YoY Growth (2021-2032) & (US$ Million) Figure 31. Europe HPV Testing Revenue Share by Type (2021-2032) Figure 32. Europe HPV Testing Revenue Share by Application (2021-2032) Figure 33. Europe HPV Testing Revenue Share by Country (2021-2032) Figure 34. Germany HPV Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 35. France HPV Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 36. U.K. HPV Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. Italy HPV Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. Spain HPV Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Russia HPV Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Netherlands HPV Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. Nordic Countries HPV Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 42. China HPV Testing Revenue YoY Growth (2021-2032) & (US$ Million) Figure 43. China HPV Testing Revenue Share by Type (2021-2032) Figure 44. China HPV Testing Revenue Share by Application (2021-2032) Figure 45. Asia HPV Testing Revenue YoY Growth (2021-2032) & (US$ Million) Figure 46. Asia HPV Testing Revenue Share by Type (2021-2032) Figure 47. Asia HPV Testing Revenue Share by Application (2021-2032) Figure 48. Asia HPV Testing Revenue Share by Region (2021-2032) Figure 49. Japan HPV Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 50. South Korea HPV Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 51. India HPV Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. Australia HPV Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. Taiwan HPV Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. Southeast Asia HPV Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 55. SAMEA HPV Testing Revenue YoY Growth (2021-2032) & (US$ Million) Figure 56. SAMEA HPV Testing Revenue Share by Type (2021-2032) Figure 57. SAMEA HPV Testing Revenue Share by Application (2021-2032) Figure 58. SAMEA HPV Testing Revenue Share by Country (2021-2032) Figure 59. Brazil HPV Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 60. Argentina HPV Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 61. Chile HPV Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Colombia HPV Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Peru HPV Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Saudi Arabia HPV Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Israel HPV Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. UAE HPV Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Turkey HPV Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Iran HPV Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Egypt HPV Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 70. Years Considered Figure 71. Research Process Figure 72. Key Executives Interviewed

Scope & coverage.

Types
  • HPV Testing
  • Follow-up HPV Testing
  • Co-testing
Applications
  • Cervical Cancer Screening
  • Vaginal Cancer Screening
  • Other
Companies covered
  • Qiagen
  • Roche Diagnostics
  • Hologic
  • Abbott Laboratories
  • BD
  • Seegene, Inc.

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 HPV Testing Market by Type
  3. 1.2.1 Global HPV Testing Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 HPV Testing
  5. 1.2.3 Follow-up HPV Testing
  6. 1.2.4 Co-testing
  7. 1.3 HPV Testing Market by Application
  8. 1.3.1 Global HPV Testing Market Size by Application, 2021 VS 2025 VS 2032
  9. 1.3.2 Cervical Cancer Screening
  10. 1.3.3 Vaginal Cancer Screening
  11. 1.3.4 Other
  12. 1.4 Assumptions and Limitations
  13. 1.5 Study Goals and Objectives
2 HPV Testing Market Dynamics
  1. 2.1 HPV Testing Industry Trends
  2. 2.2 HPV Testing Industry Drivers
  3. 2.3 HPV Testing Industry Opportunities and Challenges
  4. 2.4 HPV Testing Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global HPV Testing Market Perspective (2021-2032)
  2. 3.2 Global HPV Testing Growth Trends by Region
  3. 3.2.1 Global HPV Testing Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global HPV Testing Market Size by Region (2021-2026)
  5. 3.2.3 Global HPV Testing Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global HPV Testing Revenue by Players
  2. 4.1.1 Global HPV Testing Revenue by Players (2021-2026)
  3. 4.1.2 Global HPV Testing Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global HPV Testing Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global HPV Testing Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global HPV Testing Key Players Headquarters & Area Served
  7. 4.4 Global HPV Testing Players, Product Type & Application
  8. 4.5 Global HPV Testing Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global HPV Testing Market CR5 and HHI
  11. 4.6.3 2025 HPV Testing Tier 1, Tier 2, and Tier 3
5 HPV Testing Market Size by Type
  1. 5.1 Global HPV Testing Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global HPV Testing Revenue by Type (2021-2032)
  3. 5.3 Global HPV Testing Revenue Market Share by Type (2021-2032)
6 HPV Testing Market Size by Application
  1. 6.1 Global HPV Testing Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global HPV Testing Revenue by Application (2021-2032)
  3. 6.3 Global HPV Testing Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 Qiagen
  2. 7.1.1 Qiagen Company Information
  3. 7.1.2 Qiagen Business Overview
  4. 7.1.3 Qiagen HPV Testing Revenue and Gross Margin (2021-2026)
  5. 7.1.4 Qiagen HPV Testing Product Portfolio
  6. 7.1.5 Qiagen Recent Developments
  7. 7.2 Roche Diagnostics
  8. 7.2.1 Roche Diagnostics Company Information
  9. 7.2.2 Roche Diagnostics Business Overview
  10. 7.2.3 Roche Diagnostics HPV Testing Revenue and Gross Margin (2021-2026)
  11. 7.2.4 Roche Diagnostics HPV Testing Product Portfolio
  12. 7.2.5 Roche Diagnostics Recent Developments
  13. 7.3 Hologic
  14. 7.3.1 Hologic Company Information
  15. 7.3.2 Hologic Business Overview
  16. 7.3.3 Hologic HPV Testing Revenue and Gross Margin (2021-2026)
  17. 7.3.4 Hologic HPV Testing Product Portfolio
  18. 7.3.5 Hologic Recent Developments
  19. 7.4 Abbott Laboratories
  20. 7.4.1 Abbott Laboratories Company Information
  21. 7.4.2 Abbott Laboratories Business Overview
  22. 7.4.3 Abbott Laboratories HPV Testing Revenue and Gross Margin (2021-2026)
  23. 7.4.4 Abbott Laboratories HPV Testing Product Portfolio
  24. 7.4.5 Abbott Laboratories Recent Developments
  25. 7.5 BD
  26. 7.5.1 BD Company Information
  27. 7.5.2 BD Business Overview
  28. 7.5.3 BD HPV Testing Revenue and Gross Margin (2021-2026)
  29. 7.5.4 BD HPV Testing Product Portfolio
  30. 7.5.5 BD Recent Developments
  31. 7.6 Seegene, Inc.
  32. 7.6.1 Seegene, Inc. Company Information
  33. 7.6.2 Seegene, Inc. Business Overview
  34. 7.6.3 Seegene, Inc. HPV Testing Revenue and Gross Margin (2021-2026)
  35. 7.6.4 Seegene, Inc. HPV Testing Product Portfolio
  36. 7.6.5 Seegene, Inc. Recent Developments
8 North America
  1. 8.1 North America HPV Testing Revenue (2021-2032)
  2. 8.2 North America HPV Testing Revenue by Type (2021-2032)
  3. 8.2.1 North America HPV Testing Revenue by Type (2021-2026)
  4. 8.2.2 North America HPV Testing Revenue by Type (2027-2032)
  5. 8.3 North America HPV Testing Revenue Share by Type (2021-2032)
  6. 8.4 North America HPV Testing Revenue by Application (2021-2032)
  7. 8.4.1 North America HPV Testing Revenue by Application (2021-2026)
  8. 8.4.2 North America HPV Testing Revenue by Application (2027-2032)
  9. 8.5 North America HPV Testing Revenue Share by Application (2021-2032)
  10. 8.6 North America HPV Testing Revenue by Country
  11. 8.6.1 North America HPV Testing Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America HPV Testing Revenue by Country (2021-2026)
  13. 8.6.3 North America HPV Testing Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe HPV Testing Revenue (2021-2032)
  2. 9.2 Europe HPV Testing Revenue by Type (2021-2032)
  3. 9.2.1 Europe HPV Testing Revenue by Type (2021-2026)
  4. 9.2.2 Europe HPV Testing Revenue by Type (2027-2032)
  5. 9.3 Europe HPV Testing Revenue Share by Type (2021-2032)
  6. 9.4 Europe HPV Testing Revenue by Application (2021-2032)
  7. 9.4.1 Europe HPV Testing Revenue by Application (2021-2026)
  8. 9.4.2 Europe HPV Testing Revenue by Application (2027-2032)
  9. 9.5 Europe HPV Testing Revenue Share by Application (2021-2032)
  10. 9.6 Europe HPV Testing Revenue by Country
  11. 9.6.1 Europe HPV Testing Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe HPV Testing Revenue by Country (2021-2026)
  13. 9.6.3 Europe HPV Testing Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China HPV Testing Revenue (2021-2032)
  2. 10.2 China HPV Testing Revenue by Type (2021-2032)
  3. 10.2.1 China HPV Testing Revenue by Type (2021-2026)
  4. 10.2.2 China HPV Testing Revenue by Type (2027-2032)
  5. 10.3 China HPV Testing Revenue Share by Type (2021-2032)
  6. 10.4 China HPV Testing Revenue by Application (2021-2032)
  7. 10.4.1 China HPV Testing Revenue by Application (2021-2026)
  8. 10.4.2 China HPV Testing Revenue by Application (2027-2032)
  9. 10.5 China HPV Testing Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia HPV Testing Revenue (2021-2032)
  2. 11.2 Asia HPV Testing Revenue by Type (2021-2032)
  3. 11.2.1 Asia HPV Testing Revenue by Type (2021-2026)
  4. 11.2.2 Asia HPV Testing Revenue by Type (2027-2032)
  5. 11.3 Asia HPV Testing Revenue Share by Type (2021-2032)
  6. 11.4 Asia HPV Testing Revenue by Application (2021-2032)
  7. 11.4.1 Asia HPV Testing Revenue by Application (2021-2026)
  8. 11.4.2 Asia HPV Testing Revenue by Application (2027-2032)
  9. 11.5 Asia HPV Testing Revenue Share by Application (2021-2032)
  10. 11.6 Asia HPV Testing Revenue by Country
  11. 11.6.1 Asia HPV Testing Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia HPV Testing Revenue by Country (2021-2026)
  13. 11.6.3 Asia HPV Testing Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA HPV Testing Revenue (2021-2032)
  2. 12.2 SAMEA HPV Testing Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA HPV Testing Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA HPV Testing Revenue by Type (2027-2032)
  5. 12.3 SAMEA HPV Testing Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA HPV Testing Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA HPV Testing Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA HPV Testing Revenue by Application (2027-2032)
  9. 12.5 SAMEA HPV Testing Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA HPV Testing Revenue by Country
  11. 12.6.1 SAMEA HPV Testing Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA HPV Testing Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA HPV Testing Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst